GENPF

Healthcare Drug Manufacturers - Specialty & Generic

Genix Pharmaceuticals Corporation

$0.01
+0.00 +0.00% today Live

Price History

Not enough data
Price chart data
DatePrice
Oct 6, 2026, live at 1:10 PM ET0.01

Key Stats

Market Cap
844,893.008
Avg Volume
30
EPS
-$0.01
52W High
$0.04
52W Low
$0.01
Div. Yield
0.0%

Valuation

P/B Ratio
-0.79

Margins

Gross Margin 0.0%
Operating Margin 0.0%
Net Margin 0.0%
EBITDA Margin 0.0%

Growth & Returns

Return on Assets
(177.4%)

Liquidity & Leverage

Current Ratio
0.02
Quick Ratio
0.01
Total Cash
11,255
Total Debt
1.15M

About

Genix Pharmaceuticals Corporation formulates, manufactures, licenses, and markets life sciences related products with a focus on nutraceuticals and pharmaceuticals in Canada. The company offers generic ophthalmic prescription products, ophthalmic nutraceutical formulations, and prescription generic drugs; ophthalmic OTC products; and eye ointments and drops. It also provides Flu-X, an anti-viral, anti-flu, and common colds coronavirus oral and spray herbal product; Rechlor, a dietary supplement to support kidney health; Sucanon, an herbal health supplement to manage blood sugar levels and enhance insulin sensitivity in non-insulin dependent adults; and Synthroid, a levothyroxine sodium drug for the treatment of hypothyroidism. The company was formerly known as Alta Natural Herbs & Supplements Ltd. and changed its name to Genix Pharmaceuticals Corporation in June 2019. Genix Pharmaceuticals Corporation was incorporated in 1993 and is based in Vancouver, Canada.

genixpharm.com